FDA
- Status: approved
Quadravalent human papillomavirus vaccine (Quadravalent human papillomavirus vaccine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
The Hospital for Sick Children is the originator. The local marketing authorisation holder may differ — check the official source linked above.